Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT)

v3.23.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Common Stock
Additional paid-in capital
Accumulated deficit
Total
Beginning Balances at Dec. 31, 2021 $ 13 $ 43,387 $ (14,444) $ 28,956
Beginning Balances (in shares) at Dec. 31, 2021 645,943      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Exercise of stock options   4   4
Exercise of stock options (in shares) 40      
Share issuance, net $ 6 5,189   5,195
Share issuance, net (in shares) 278,804      
Stock-based compensation   464   464
Stock-based compensation (in shares) 843      
Net loss     (8,618) (8,618)
Ending Balance at Sep. 30, 2022 $ 19 49,044 (23,062) 26,001
Ending Balance (in shares) at Sep. 30, 2022 925,630      
Beginning Balances at Dec. 31, 2021 $ 13 43,387 (14,444) 28,956
Beginning Balances (in shares) at Dec. 31, 2021 645,943      
Ending Balance at Dec. 31, 2022 $ 21 50,000 (44,556) 5,465
Ending Balance (in shares) at Dec. 31, 2022 1,051,098      
Beginning Balances at Jun. 30, 2022 $ 13 43,963 (21,629) 22,347
Beginning Balances (in shares) at Jun. 30, 2022 645,983      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share issuance, net $ 6 5,189   5,195
Share issuance, net (in shares) 278,804      
Stock-based compensation   (108)   (108)
Stock-based compensation (in shares) 843      
Net loss     (1,433) (1,433)
Ending Balance at Sep. 30, 2022 $ 19 49,044 (23,062) 26,001
Ending Balance (in shares) at Sep. 30, 2022 925,630      
Beginning Balances at Dec. 31, 2022 $ 21 50,000 (44,556) 5,465
Beginning Balances (in shares) at Dec. 31, 2022 1,051,098      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Share issuance, net $ 5 5,378   5,383
Share issuance, net (in shares) 4,091,667      
Stock-based compensation   (107)   (107)
Stock-based compensation (in shares) 268,081      
Net loss     (17,015) (17,015)
Exercise of warrants (in shares) 750,000      
Share issuance, acquisition related $ 1 204   205
Share issuance, acquisition related (in shares) 547,946      
Fractional shares issued related to reverse split (shares) 11,168      
Ending Balance at Sep. 30, 2023 $ 27 55,475 (61,571) (6,069)
Ending Balance (in shares) at Sep. 30, 2023 6,719,960      
Beginning Balances at Jun. 30, 2023 $ 26 55,434 (54,132) 1,328
Beginning Balances (in shares) at Jun. 30, 2023 5,422,014      
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation   (163)   (163)
Net loss     (7,439) (7,439)
Exercise of warrants (in shares) 750,000      
Share issuance, acquisition related $ 1 204   205
Share issuance, acquisition related (in shares) 547,946      
Ending Balance at Sep. 30, 2023 $ 27 $ 55,475 $ (61,571) $ (6,069)
Ending Balance (in shares) at Sep. 30, 2023 6,719,960